(Q40171755)

English

Intervention for the prevention and control of hypertension and atherosclerotic diseases: United States and international experience

scientific article published on February 27, 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

Intervention for the prevention and control of hypertension and atherosclerotic diseases: United States and international experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

J. Stamler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6367448

9 October 2023

R. Stamler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6367448

9 October 2023

language of work or name

0 references

publication date

1 February 1984

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

27 February 1984

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6367448

9 October 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0002934384909537?httpAccept=text/xml

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

https://api.elsevier.com/content/article/PII:0002934384909537?httpAccept=text/plain

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

2A

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

13-36

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group

5

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

George Lyman Duff Memorial Lecture. Lifestyles, major risk factors, proof and public policy

6

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Epidemiology of coronary heart disease: the Framingham study.

21

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

23

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Pharmacological trials: primary and secondary prevention of coronary heart disease

25

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet

28

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The Anti-Coronary Club; Including a Discussion of the Effects of a Prudent Diet on the Serum Cholesterol Level of Middle-Aged Men

29

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Fats, cholesterol, and coronary heart disease

30

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report

31

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The Anti-Coronary Club: 1957 to 1972.

34

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

36

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Dietary Prevention of Coronary Heart Disease: The Finnish Mental Hospital Study

37

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The National Diet-Heart Study Final Report

38

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality

40

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

42

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study

43

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

45

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen

47

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia

48

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

49

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The effects of smoking

54

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Coronary Heart Disease, Stroke, and Aortic Aneurysm

60

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Smoking and causes of death among U.S. veterans: 16 years of observation

61

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Trends in mortality among California physicians after giving up smoking: 1950-79.

62

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Feasibility of altering type A behavior pattern after myocardial infarction. Recurrent Coronary Prevention Project Study: methods, baseline results and preliminary findings

65

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects

68

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

70

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension

71

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Blood pressure studies in 14 communities. A two-stage screen for hypertension

72

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group

74

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The impact of selected indices of antihypertensive treatment on all-cause mortality

79

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effectiveness of a low saturated fat, low cholesterol, weight-reducing diet for the control of hypertriglycer-idemia

83

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Plasma glucose levels: long-term effect of diet in the Chicago Coronary Prevention Evaluation Program

84

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Smoking cessation in the Chicago Coronary Prevention Evaluation Program

88

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Regression and Progression of Early Femoral Atherosclerosis in Treated Hyperlipoproteinemic Patients

89

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids.

92

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial

93

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

94

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Overweight and hypertension. A review

97

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Hypertension: comparison of drug and non-drug treatments

98

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Relation of weight change to changes in atherogenic traits: The Framingham study

99

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

100

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Cardiovascular Changes After Weight Reduction in Obesity Hypertension

101

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Reduced thermogenesis in obesity

102

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

103

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients

104

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Salt and hypertension

105

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Mild hypertension--appropriate diagnostic work-up: discussion

107

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Moderate sodium restriction and diuretics in the treatment of hypertension

108

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Hypertension treated by salt restriction

111

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Randomised controlled trial of a no-added-sodium diet for mild hypertension

113

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension

114

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Salt restriction and no drug treatment in mild to moderate hypertension

116

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension

117

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Dietary sodium restriction for mild hypertension in general practice

118

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Controlled, randomised trial of the effect of dietary fat on blood pressure

119

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Treatment of hypertensive vascular disease with rice diet

120

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients

121

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The Use of Sodium Chloride, Potassium Chloride, Sodium Bromide, and Potassium Bromide in Cases of Arterial Hypertension which are Amenable to Potassium Chloride

122

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Moderate potassium supplementation in essential hypertension

124

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Reduction of Blood Pressure With Calcium Supplementation in Young Adults

125

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effect of magnesium on blood pressure.

126

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Alcohol-induced hypertension

127

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Re-analysis of data in two Lancet papers on the effect of dietary sodium and potassium on blood pressure

128

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effect of moderate salt restriction and high potassium intake on pressor hormones, response to noradrenaline and baroreceptor function in man.

129

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action

130

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Reduction of blood pressure associated with dietary polyunsaturated fat

131

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

The role of dietary polyunsaturated fatty acids and prostaglandins in reducing blood pressure and improving thrombogenic indices

132

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease

133

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Blood-pressure-lowering effect of a vegetarian diet: controlled trial in normotensive subjects

134

1 reference

10.1016/0002-9343(84)90953-7

https://api.crossref.org/works/10.1016/0002-9343(84)90953-7

9 October 2023

Identifiers

10.1016/0002-9343(84)90953-7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40171755&oldid=1989162668"